Embolic stroke of undetermined source (ESUS) refers to ischemic stroke where the underlying cause of thromboembolism cannot be found despite the recommended diagnostic workup. Unidentified source of emboli hinders clinical decision-making and patient management with detrimental consequences on long-term prognosis. The rapid development and versatility of magnetic resonance imaging (MRI) make it an appealing addition to the diagnostic routine of patients with ESUS for the assessment of potential vascular and cardiac embolic sources.
Aims:
To review the use of MRI in the identification of cardiac and vascular embolic sources in ESUS and to assess the reclassification value of MRI examinations added to the conventional workup of ESUS.
Summary of review:
We reviewed the use of cardiac and vascular MRI for the identification of a variety of embolic sources associated with ESUS, including atrial cardiomyopathy, left ventricular pathologies, and supracervical atherosclerosis in carotid and intracranial arteries and in distal thoracic aorta. The additional reclassification after MRI examinations added to the workup of patients with ESUS ranged from 6.1% to 82.3% and varied depending on the combination of imaging modalities.
Conclusion:
MRI techniques allow us to identify additional cardiac and vascular embolic sources and may further decrease the prevalence of patients with the diagnosis of ESUS.
NtaiosGPapavasileiouVMilionisH, et al. Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis. Stroke2015; 46: 176–181.
3.
HartRGDienerHCCouttsSB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol2014; 13: 429–438.
4.
HartRGCataneseLPereraKSNtaiosGConnollySJ. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke2017; 48: 867–872.
5.
DienerH-CSaccoRLEastonJD, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med2019; 380: 1906–1917.
6.
TandonKTirschwellDLongstrethWT, et al. Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillation. Neurology2019; 93: e381–e387.
7.
KühnleinPMahnkopfCMajersikJJ, et al. Atrial fibrosis in embolic stroke of undetermined source: a multicenter study. Eur J Neurol2021; 28: 3634–3639.
8.
FonsecaACAlvesPInácioN, et al. Patients with undetermined stroke have increased atrial fibrosis: a cardiac magnetic resonance imaging study. Stroke2018; 49: 734–737.
9.
KromanAMahnkopfCKühnleinP, et al. Abstract: 11540 embolic stroke of unknown source is associated with atrial fibrosis similar to atrial fibrillation. Circulation2019; 140: A11540.
10.
DaccarettMBadgerTJAkoumN, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol2011; 57: 831–838.
11.
AkoumNFernandezGWilsonBMcgannCKholmovskiEMarroucheN. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol2013; 24: 1104–1109.
12.
HongYJHurJKimYJ, et al. The usefulness of delayed contrast-enhanced cardiovascular magnetic resonance imaging in differentiating cardiac tumors from thrombi in stroke patients. Int J Cardiovasc Imaging2011; 27: 89–95.
13.
VelangiPSChooCChenKA, et al. Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study. Circ Cardiovasc Imaging2019; 12: e009723.
14.
HaeuslerKGWollboldtCBentheimLZ, et al. Feasibility and diagnostic value of cardiovascular magnetic resonance imaging after acute ischemic stroke of undetermined origin. Stroke2017; 48: 1241–1247.
15.
MerklerAESigurdssonSEiriksdottirG, et al. Association between unrecognized myocardial infarction and cerebral infarction on magnetic resonance imaging. JAMA Neurol2019; 76: 956–961.
16.
ToupinSPezelTSanguinetiF, et al. Additional prognostic value of stress cardiovascular magnetic resonance for cardiovascular risk stratification after a cryptogenic ischemic stroke. Front Cardiovasc Med2022; 9: 956950.
17.
FonsecaACMartoJPPimentaD, et al. Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance. Neurology2020; 94: e107–e113.
18.
PöyhönenPKuusistoJJärvinenV, et al. Left ventricular non-compaction as a potential source for cryptogenic ischemic stroke in the young: a case-control study. PLoS ONE2020; 15: e0237228.
19.
SinghNMoodyARPanzovVGladstoneDJ. Carotid intraplaque hemorrhage in patients with embolic stroke of undetermined source. J Stroke Cerebrovasc Dis2018; 27: 1956–1959.
20.
HyafilFSchindlerASeppD, et al. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined 18 F-FDG PET/MR imaging. Eur J Nucl Med Mol Imaging2016; 43: 270–279.
21.
KopczakASchindlerABayer-KarpinskaA, et al. Complicated carotid artery plaques as a cause of cryptogenic stroke. J Am Coll Cardiol2020; 76: 2212–2222.
22.
FreilingerTMSchindlerASchmidtC, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging2012; 5: 397–405.
23.
Bayer-KarpinskaASchwarzFWollenweberFA, et al. The carotid plaque imaging in acute stroke (CAPIAS) study: protocol and initial baseline data. BMC Neurol2013; 13: 1–10.
24.
KamelHNaviBBMerklerAE, et al. Reclassification of ischemic stroke etiological subtypes on the basis of high-risk nonstenosing carotid plaque. Stroke2020; 51: 504–510.
25.
GuptaAGialdiniGLerarioMP, et al. Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke. J Am Heart Assoc2015; 4: e002012.
26.
NardiVBensonJBoisMC, et al. Carotid plaques from symptomatic patients with mild stenosis is associated with intraplaque hemorrhage. Hypertension2022; 79: 271–282.
27.
ChungJWKimBJChoiBS, et al. High-resolution magnetic resonance imaging reveals hidden etiologies of symptomatic vertebral arterial lesions. J Stroke Cerebrovasc Dis2014; 23: 293–302.
28.
SchaafsmaJDRawalSCoutinhoJM, et al. Diagnostic impact of intracranial vessel wall MRI in 205 patients with ischemic stroke or TIA. Am J Neuroradiol2019; 40: 1701–1706.
29.
TaoLLiX-QHouX-W, et al. Intracranial atherosclerotic plaque as a potential cause of embolic stroke of undetermined source. J Am Coll Cardiol2021; 77: 680–691.
30.
LuoNShangZYTaoLYangBQChenHS. Atherosclerosis as a potential cause of deep embolic stroke of undetermined source: a 3T high-resolution magnetic resonance imaging study. J Am Heart Assoc2022; 11: e026737.
31.
FakihRRoaJABathlaG, et al. Detection and quantification of symptomatic atherosclerotic plaques with high-resolution imaging in cryptogenic stroke. Stroke2020; 51: 3623–3631.
32.
ShangZTaoLLiX, et al. The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: an analysis of different subtypes based on high-resolution imaging. Eur J Neurol2022; 29: 2654–2663.
33.
MazzacaneFZitoAMagnoS, et al. Vessel wall magnetic resonance imaging in COVID-19 associated cryptogenic ischemic stroke. Eur J Neurol2022; 29: 615–619.
34.
WehrumTDragonuIStreckerC, et al. Aortic atheroma as a source of stroke–assessment of embolization risk using 3D CMR in stroke patients and controls. J Cardiovasc Magn Reson2017; 19: 1–9.
35.
WehrumTKamsMStreckerC, et al. Prevalence of potential retrograde embolization pathways in the proximal descending aorta in stroke patients and controls. Cerebrovasc Dis2014; 38: 410–417.
36.
HarloffASimonJBrendeckeS. Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke. J Vasc Surg2011; 53: 1752.
37.
HarloffAStreckerCDudlerP, et al. Retrograde embolism from the descending aorta: visualization by multidirectional 3D velocity mapping in cryptogenic stroke. Stroke2009; 40: 1505–1508.
38.
HarloffADudlerPFrydrychowiczA, et al. Reliability of aortic MRI at 3 Tesla in patients with acute cryptogenic stroke. J Neurol Neurosurg Psychiatry2008; 79: 540–546.
39.
JarvisKValiAShenX, et al. Elevated pulse wave velocity is associated with regional aortic flow reversal as an embolic mechanism in patients with cryptogenic stroke. Stroke2018; 49: A122.
40.
MarklMSemaanEStrombergLCarrJPrabhakaranSCollinsJ. Importance of variants in cerebrovascular anatomy for potential retrograde embolization in cryptogenic stroke. Eur Radiol2017; 27: 4145–4152.
41.
MoriharaKNakanoTMoriK, et al. Usefulness of rapid MR angiography using two-point Dixon for evaluating carotid and aortic plaques. Neuroradiology2022; 64: 693–702.
42.
BaherAMowlaAKodaliS, et al. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis2014; 37: 277–284.
43.
TakasugiJYamagamiHNoguchiT, et al. Detection of left ventricular thrombus by cardiac magnetic resonance in embolic stroke of undetermined source. Stroke2017; 48: 2434–2440.
44.
LibermanALKalaniREAw-ZoreticJ, et al. Cardiac magnetic resonance imaging has limited additional yield in cryptogenic stroke evaluation after transesophageal echocardiography. Int J Stroke2017; 12: 946–952.
45.
KesavPKrishnavadanaBKesavadasC, et al. Utility of intracranial high-resolution vessel wall magnetic resonance imaging in differentiating intracranial vasculopathic diseases causing ischemic stroke. Neuroradiology2019; 61: 389–396.
46.
TandonVSenthilvelanSSreedharanSEKesavadasCVtJSylajaPN. High-resolution MR vessel wall imaging in determining the stroke aetiology and risk stratification in isolated middle cerebral artery disease. Neuroradiology2022; 64: 1569–1577.
KotadiaIDO’DowlingRAboagyeA, et al. Atrial CARdiac Magnetic resonance imaging in patients with embolic stroke of unknown source without documented Atrial Fibrillation (CARM-AF): study design and clinical protocol. Heart Rhythm O22022; 3: 196–203.
49.
FonsecaACFerroJMAlmeidaAG. Cardiovascular magnetic resonance imaging and its role in the investigation of stroke: an update. J Neurol2021; 268: 2597–2604.
50.
HohneckAOverhoffDDoeschC, et al. Extent of late gadolinium enhancement predicts thromboembolic events in patients with hypertrophic cardiomyopathy. Circ J2020; 84: 754–762.
51.
AdamsHPJrBendixenBHKappelleLJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke1993; 24: 35–41.
52.
NtaiosGWintermarkMMichelP. Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source. Eur Heart J2021; 42: 1789–1796.
53.
CaiJ-MHatsukamiTSFergusonMS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation2002; 106: 1368–1373.
54.
Kamtchum-TatueneJWilmanASaqqurMShuaibAJicklingGC. Carotid plaque with high-risk features in embolic stroke of undetermined source: systematic review and meta-analysis. Stroke2020; 51: 311–314.
55.
AmerisoSFAmarencoPPearceLA, et al. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: recurrent stroke risk and response to antithrombotic therapy. J Stroke Cerebrovasc Dis2020; 29: 104936.
56.
YangRYuanJChenX, et al. Vessel wall magnetic resonance imaging of symptomatic middle cerebral artery atherosclerosis: a systematic review and meta-analysis. Clin Imaging2022; 9: 90–96.
57.
NtaiosGPearceLAMeseguerE, et al. Aortic arch atherosclerosis in patients with embolic stroke of undetermined source: an exploratory analysis of the NAVIGATE ESUS trial. Stroke2019; 50: 3184–3190.
58.
HarloffAHandkeMReinhardMGeibelAHetzelA. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke2006; 37: 859–864.
59.
HartRGSharmaMMundlH, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med2018; 378: 2191–2201.
60.
KamelHLongstrethWTJrTirschwellDL, et al. The AtRial Cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke2019; 14: 207–214.
61.
CapturGLobascioIYeY, et al. Motion-corrected free-breathing LGE delivers high quality imaging and reduces scan time by half: an independent validation study. Int J Cardiovasc Imaging2019; 35: 1893–1901.
62.
LeeDCMarklMNgJ, et al. Three-dimensional left atrial blood flow characteristics in patients with atrial fibrillation assessed by 4D flow CMR. Eur J Echocardiogr2015; 17: 1259–1268.
63.
WangCZhangYDuJ, et al. Quantitative susceptibility mapping for characterization of intraplaque hemorrhage and calcification in carotid atherosclerotic disease. J Magn Reson Imaging2020; 52: 534–541.
64.
MuscogiuriGVolpatoVCauR, et al. Application of AI in cardiovascular multimodality imaging. Heliyon2022; 8: e10872.
65.
YanSZhouYHanQChenYLouM. Potential role of 2-phase cardiac CT in patients with embolic stroke of undetermined source. Am J Med2020; 133: e290–e293.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
